Claus Crone Fuglsang

This inventor holds 34 USPTO granted patents and 8 published patent applications and 2 EPO patents, primarily in Enzyme Variants. Top assignees: Novo Nordisk A/s, Novozymes A/s, Novo Nordisk Biotech, Inc.. Active years: 1997-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claus Crone Fuglsang. Retrieved from https://idiyas.com/inventor/claus-crone-fuglsang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 8)

% Patents Active = 76.5

EPO Patents = 2 (Patent Applications = 14)

Average Co-Inventor Count = 4.2

ph-index = 8

Forward Citations = 386(Granted Patents)

Location History:

Copenhaven NV, DK (1997)
Copenhagen, DK (1997 - 1999)
Niv.ang., DK (2000)
2990 Nivaa, DK (2001)
Nivå, DK (2001 - 2007)
Nivaa, DK (2002 - 2007)
Vekso, DK (2007 - 2010)
Niva, DK (2000 - 2014)

Company Filing History:

Novo Nordisk Biotech, Inc.

7. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2014

Loading Chart...

Areas of Expertise:

Lipolytic Enzyme Variants

Phytase Polypeptides

Carbohydrate Oxidase

Alpha-Amylase Mutants

Enzymatic Preservation

Dough Preparation

Oral Care Products

Metalloprotease Activity

Dextranase Activity

Peniophora Phytase

Haloperoxidases

Antimicrobial Activity

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8679774 - Lipolytic enzyme variants (2014-03-25),

2. 7851176 - Lipolytic enzyme variants (2010-12-14),

3. 7713723 - Alpha-amylase mutants with altered properties (2010-05-11),

4. 7700338 - CGTase and DNA sequence encoding same (2010-04-20),

5. 7632669 - Lipolytic enzyme variants (2009-12-15),

6. 7312062 - Lipolytic enzyme variants (2007-12-25),

7. 7238378 - Phytase variants (2007-07-03),

8. 7238350 - Phytase polypeptides (2007-07-03),

9. 7157262 - Lipolytic enzymes (2007-01-02),

10. 7063970 - Enzymatic preservation of water based paints (2006-06-20),

11. 7060474 - Carbohydrate oxidase and use thereof in baking (2006-06-13),

12. 6900039 - Carbohydrate oxidase and use thereof in baking (2005-05-31),

13. 6569659 - Phytase polypeptides (2003-05-27),

14. 6495357 - Lipolytic enzymes (2002-12-17),

15. 6365204 - Preparation of dough and baked products (2002-04-02),

Title: Claus Crone Fuglsang: Innovator and Pioneer in Lipolytic Enzymes

Introduction

Claus Crone Fuglsang is a renowned inventor based in Niva, Denmark, known for his remarkable contributions to the field of enzyme technology. With a total of 33 patents to his name, Fuglsang has significantly advanced the understanding and application of lipolytic enzymes.

Latest Patents

Fuglsang's latest patents focus on the innovative development of lipolytic enzyme variants. These patents describe how the substrate specificity of a lipolytic enzyme can be modified by altering specific amino acid sequences. Such modifications enable the increase of desired activities while reducing undesired ones, resulting in tailored enzyme variants suitable for various applications. This breakthrough in enzyme technology highlights Fuglsang's commitment to enhancing enzyme efficacy.

Career Highlights

Throughout his career, Claus Crone Fuglsang has made substantial contributions to prominent companies such as Novo Nordisk A/S and Novozymes A/S. His work in these leading organizations has been instrumental in pioneering new advancements in biotechnological applications. Fuglsang's expertise in enzyme modification has positioned him as a key figure in the research and development sector.

Collaborations

Fuglsang has collaborated with esteemed coworkers, including Torben Halkier and Shamkant Anant Patkar. Their collective efforts in enzyme research have led to significant innovations, further propelling the field forward. The collaboration among these talented individuals underscores the importance of teamwork in scientific advancements.

Conclusion

Claus Crone Fuglsang's innovative spirit and extensive patent portfolio demonstrate his vital role in the realm of lipolytic enzyme development. His contributions not only enhance scientific knowledge but also pave the way for practical applications in various industries. As a recognized inventor, Fuglsang continues to impact the enzyme technology landscape, inspiring future innovations.

Profile summary based on public USPTO records.